This past April, 3P Biopharmaceuticals obtained GMP (Good Manufacturing Practices) certification for a manufacturing process of a cellular medication destined for allogeneic therapy treatments
Read moreWith more than 60% of its portfoloio composed of international clients, 3P has active presence in major international markets such as USA, Australia, Mexico, Argentina, France, Norway, Italy, UK, Belg...
Read moreThe project has received funding from the European Union’s Seventh Framework Programme and aims to develop a non-viral gene therapeutic approach for the treatment of this neurodegenerative disease o...
Read more"The challenge of Partner selection: the best travel companion in biologics drug development adventure” will discover the keys to success in this major challenge
Read moreEl proyecto EU-ToxRisk, coordinado por Bob van de Water, catedrático de Toxicología en la Universidad de Leiden (Holanda), busca convertirse en el líder europeo en evaluación de la seguridad quím...
Read moreKymos realiza controles de calidad de medicamentos o de sus componentes, estudios de bioequivalencia, estudios de estabilidad para determinar la caducidad o, en investigación, análisis de muestras d...
Read moreInKemia informa que el grupo ha realizado la compra de las participaciones del segundo mayor accionista de Recerca Clínica, S.L. por valor de 75.000 euros. Así mismo suscribe una ampliación de capi...
Read moreLa EMA (European Medicines Agency), retoma el desarrollo del Nuevo portal para la presentación online de ensayos clínicos a nivel europeo (UATs European Portal). Éste Octubre 2017 se llevará a cab...
Read moreMind the Byte, a bioinformatics company located at the Barcelona Science Park (PCB) and at Copenhagen BioScience Park (COBIS), announces that it has just signed an agreement to share technology with t...
Read moreEl Vall d'Hebron Barcelona Campus Hospitalario y Pharmaceutical Product Development LLC (PPD), una de las Contract Research Organization (CRO) líderes a nivel mundial, han renovado su acuerdo de cola...
Read moreSermes CRO, a company with more than 10 years dedicated to the health sector and clinical research, have signed an agreement with Quirónsalud for conducting clinical trials, observational studies and...
Read moreOn Tuesday, October 23rd, the European Society for Medical Oncology Congress (ESMO) ended its annual Congress in Munich with over 26,000 oncology professionals from all over the world. This congress w...
Read more